echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > The UK has introduced an anti-CGRP single anti-Ajovy pre-filled pen for migraines: patients can inject themselves.

    The UK has introduced an anti-CGRP single anti-Ajovy pre-filled pen for migraines: patients can inject themselves.

    • Last Update: 2020-10-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Teva UK has launched Ajovy's pre-filled pen in the UK, providing migraine sufferers with a more convenient and flexible way to do it than syringes and can manage it at home.
    Ajovy is an all-human monoclonal antibody that targets calcitonin gene-related peptides (CGRP) to prevent migraines at least four times a month in adults.
    : The drug is the first and only anti-CGRP drug recommended by the NHS for patients with chronic migraines.
    new Ajovy pre-fill pen developed in the UK, including buttonless, push-down, audible signals, instructions for management progress, and windows showing dose delivery.
    can be injected into areas of the abdomen, thighs, or upper arm that do not have bruises, redness, or hard knots.
    Mark Weatherall, chairman of the British Headache Research Association, said: "Migraines are a debilitating neurological condition that, if left untreated, can strike at any time and make patients feel helpless.
    "Fremanezumab is effective and well-um-resistant and is particularly useful for complex migraine patients who are not available for other treatments.
    pre-filled pen is easy to self-manage and enhances patients' control over their condition.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.